直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Prosecution First Blog

Speed Up Patent Prosecution? Think PPH

September 22, 2023

Authored and Edited by Adriana L. Burgy; Stacy Lewis†

The USPTO implemented the Patent Prosecution Highway (PPH) back in May of 2010. It has been around for a while but sometimes a forgotten tool in some technology fields. The PPH is a work-sharing arrangement between national and regional patent offices enabling an applicant who receives a positive ruling on patent claims from one participating office to request accelerated prosecution of corresponding claims in another participating office. The objective is to save time and money. For example, for FY22 (Oct 2021 – Sept 2022), in participating patent offices with at least 100 petitions filed,[1] the average pendency in days from petition to a First Action was 144 (roughly 4.8 months).[2] By comparison, the USPTO First Office Action Pendency averages about 16 months.[3]  Currently, there are 55 national and regional patent offices countries participating in the Global PPH. See https://www.jpo.go.jp/e/toppage/pph-portal/network.html.  

The USPTO also participates in bilateral PPH agreements with patent offices in several countries and regions. See https://www.uspto.gov/patents/basics/international-protection/patent-prosecution-highway-pph-fast-track. Most recently, the USPTO entered into bilateral PPH pilot programs with Morocco (effective April 1, 2023), Malaysia (effective March 2, 2023 to March 3, 2026), France (effective Dec. 1, 2021 to Nov. 30, 2024), and Brazil (effective Dec. 1, 2019 to Nov. 30, 2024).

In addition, there is a IP5 PPH pilot program among IP5 offices: the USPTO, the China National Intellectual Property Administration (CNIPA), the European Patent Office (EPO), the Japan Patent Office (JPO), and the Korean Intellectual Property Office (KIPO). The IP5 PPH pilot program allows an applicant whose claims have been allowed by one IP5 office to have the corresponding application filed in another IP5 office advanced out of turn for examination.

On January 30, 2023, the IP5 offices agreed to extend the pilot until January 5, 2026. The European Patent Office (EPO) announced that it is making the IP5 PPH pilot program permanent.

As of August 31, 2023, roughly 88,354 applications with petitions have been filed with the USPTO through the PPH program. Of these, there have been 78,944 applications with petitions granted.[4]

Your USPTO patent application is eligible for PPH if:

1) Your USPTO application shares a common earliest priority date with a related application from a partnering PPH office (http://www.uspto.gov/patents/init_events/pph/index.jsp);

2) You have received an indication of allowability for at least one claim in the related application;

3) All claims in your USPTO application sufficiently correspond (see Question 27 below) to allowable claims in the related application; and

4) Substantive examination has not begun on your USPTO application.  If you have received a restriction requirement in the U.S. application, your U.S. application may still be eligible to participate in the PPH program if the examiner has not started on the first action on the merits.[5] 

Provisional applications, plant applications, design applications, reissue applications, reexamination proceedings, and applications subject to a secrecy order are not eligible for the PPH program.[6]

Endnotes

[1] Patent Offices in Canada, China, Europe, Japan, Korea, UK, and US.

[2] Source: https://www.uspto.gov/sites/default/files/documents/PPHQuarterlyStatisticsDataFY2021.pdf.

[3] Source: https://www.uspto.gov/dashboard/patents/pendency.html.

[4] Source: https://www.uspto.gov/sites/default/files/documents/PPHQuarterlyStatisticsDataFY2021.pdf.

[5] Source: https://www.uspto.gov/sites/default/files/documents/FAQs-for-PPH-revised-05032023.pdf.

[6] Source: https://www.uspto.gov/sites/default/files/documents/FAQs-for-PPH-revised-05032023.pdf.

 

Tags

United States Patent and Trademark Office (USPTO), Patent Prosecution Highway

Related Practices

Prosecution and Portfolio Management

Patent Drafting and Prosecution

Related Offices

Washington, DC

Contacts

Adriana L. Burgy
Partner
Washington, DC
+1 202 408 4345
Email

†Stacy Lewis is a Law Clerk at Finnegan.

Copyright © 2023 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Lecture

IPIC/McGill Summer IP Course 2026: Understanding Trademarks

July 14, 2026

Montreal

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Conference

IPBC Global 2026

June 15-17, 2026

San Diego

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

Conference

BIA Start-up Festival

May 21, 2026

London

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Virtual Seminar

Patent "Basics" Seminar

May 19, 2026

Virtual

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP